country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Country or Region:

United States

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

Art. -Nr.: HY-N14033

Copy Link Print Information

Luminacin C1

Luminacin C1 has a strong inhibitory effect on capillary formation (IC₅₀ is less than 0.1 μg/mL).

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

CAS. Nr.: 251449-89-5
Formel: C₂₂H₂₇NO₆
Molecular Weight:401.45

Speicherung:

Please store the product under the recommended conditions in the Certificate of Analysis.

Data Sheet (264 KB)

Luminacin C1 Chemical Structure

CAS. Nr.: 251449-89-5

Größe

Preis

Verfügbarkeit

Menge

Amount: USD 0.00

* Bitte wählen Sie Menge, bevor Sie Artikel hinzufügen.

Use of MCE Products

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

Biologische Aktivität
- Beschreibung
- Cellular Effect
Chemical Information
Reinheit & Dokumentation
Verweise
Calculators
Help & FAQs
Classifications
Bioz

Biologische Aktivität

Beschreibung

Luminacin C1 has a strong inhibitory effect on capillary formation (IC₅₀ is less than 0.1 μg/mL)^[1].

Alle Adrenergic Receptor Isoform-spezifische Produkte anzeigen :

Cellular Effect

Cell Line	Type	Value	Description	References
HeLa	IC₅₀	24.9 μM Compound: Lucilactaene	Cytotoxicity against human HeLa cells assessed as growth inhibition Cytotoxicity against human HeLa cells assessed as growth inhibition	[PMID: 34949088]
HL-60	IC₅₀	17.4 μM Compound: Lucilactaene	Cytotoxicity against human HL-60 cells assessed as growth inhibition Cytotoxicity against human HL-60 cells assessed as growth inhibition	[PMID: 34949088]

Chemical Information

CAS. Nr. 251449-89-5
Molecular Weight 401.45
Formel C₂₂H₂₇NO₆
SMILES

COC(C(/C=C(C)/C=C/C=C/C=C(C)/C([C@@H]1[C@]2([H])[C@](NC1=O)(CCO2)O)=O)=C/C)=O
Structure Classification
- Others
Initial Source
- Microorganisms
Streptomyces sp. Mer-VD1207
Versand

Room temperature in continental US; may vary elsewhere.
Speicherung

Please store the product under the recommended conditions in the Certificate of Analysis.

Reinheit & Dokumentation

Select Batch:

Reinheit: 99.98%

Assay: 99.98%

ee.: 99.98%

Data Sheet (264 KB)
COA (2659 KB)
Elemental Analysis Report (2659 KB)
HNMR (2659 KB)
CNMR (2659 KB)
RP-HPLC (2659 KB)
NP-HPLC (2659 KB)
MS (2659 KB)
LCMS (2659 KB)
IR (2659 KB)
GC (2659 KB)
OR (2659 KB)
SDS-PAGE (2659 KB)
SEC-HPLC (2659 KB)
Other Report (2659 KB)
Handling Instructions (2659 KB)

Verweise

[1]. Wakabayashi T, et al. Luminacins: a family of capillary tube formation inhibitors from Streptomyces sp. II. Biological activities. J Antibiot (Tokyo). 2000 Jun;53(6):591-6. [Content Brief]

Calculators

Molaritätsrechner

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Konzentration Konzentration

Volumen Volumen

Molecular Weight Molecular Weight

Verdünnungsrechner

Konzentration _{(Stammlösung)} × Volumen _{(Stammlösung)} = Konzentration _{(Ziellösung)} × Volumen _{(Ziellösung)}

Konzentration _{(Stammlösung)} Konzentration _{(Stammlösung)}

Volumen _{(Stammlösung)} Volumen _{(Stammlösung)}

Konzentration _{(Ziellösung)} Konzentration _{(Ziellösung)}

Volumen _{(Ziellösung)} Volumen _{(Ziellösung)}

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Bioz

Keywords

MOQ

Minimum order quantity

100 mg

Angebot einholen Auf Lager

Other size

Angebot einholen